Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
4,594 results
- Clinical Study of the Endotracheal Tube Used in Prone Position Ventilation Condition: Complete Statistical AnalysisIndependent statistical analysis of Clinical Study of the Endotracheal Tube Used in Prone Position Ventilation Condition: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Clinical Study of the Immunogenicity of GSK Biologicals’ Influenza Vaccine GSK2186877A in People Aged 65 Years or Older: Complete Statistical AnalysisIndependent statistical analysis of Clinical Study of the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in People Aged 65 Years or Older: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Clinical Study on Silk Sericin Wound Dressing for Split-thickness Skin Graft Donor Sites Treatment: Complete Statistical AnalysisIndependent statistical analysis of Clinical Study on Silk Sericin Wound Dressing for Split-thickness Skin Graft Donor Sites Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Clinical Study to Compare Two Skin Substitute Categories for Their Effectiveness to Treat Diabetic Foot Ulcers: Complete Statistical AnalysisIndependent statistical analysis of Clinical Study to Compare Two Skin Substitute Categories for Their Effectiveness to Treat Diabetic Foot Ulcers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Clinical Study to Evaluate the Safety, Immunogenicity and Efficacy of Investigational Flu Vaccine Compared to Approved Flu Vaccine in Children.: Complete Statistical AnalysisIndependent statistical analysis of Clinical Study to Evaluate the Safety, Immunogenicity and Efficacy of Investigational Flu Vaccine Compared to Approved Flu Vaccine in Children.: primary endpoint results, effect estimate with confidence interval,…
- Clinical Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% in the Treatment of Tinea Pedis: Complete Statistical AnalysisIndependent statistical analysis of Clinical Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% in the Treatment of Tinea Pedis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Clinical Study to Investigate the Effect of the Combination of Psychotropic Drugs and an Opioid on Ventilation: Complete Statistical AnalysisIndependent statistical analysis of Clinical Study to Investigate the Effect of the Combination of Psychotropic Drugs and an Opioid on Ventilation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Clinical Trial Comparing Conventional and Robot-assisted(Da Vinci®)Laparoscopic Interventions for Hysterectomy: Complete Statistical AnalysisIndependent statistical analysis of Clinical Trial Comparing Conventional and Robot-assisted(Da Vinci®)Laparoscopic Interventions for Hysterectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00683293).
- Clinical Trial of a Nutritional Supplement in Adults With Bipolar Disorder: Complete Statistical AnalysisIndependent statistical analysis of Clinical Trial of a Nutritional Supplement in Adults With Bipolar Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03646123).
- Clinical Trial to Assess the Efficacy and Safety of ‘Immuncell-LC’ With Temozolomide in Newly Diagnosed Glioblastoma of Korea: Complete Statistical AnalysisIndependent statistical analysis of Clinical Trial to Assess the Efficacy and Safety of 'Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Clinical Trial to Evaluate the Chronic Efficacy of OC-01 Nasal Spray on Signs of Dry Eye Disease (The MYSTIC Study): Complete Statistical AnalysisIndependent statistical analysis of Clinical Trial to Evaluate the Chronic Efficacy of OC-01 Nasal Spray on Signs of Dry Eye Disease (The MYSTIC Study): primary endpoint results, effect estimate with confidence interval,…
- Clinical Trial to Evaluate the Symptoms in Symptomatic Contact Lens Wearers Following Application of Intranasal Tear Neurostimulator Versus Control: Complete Statistical AnalysisIndependent statistical analysis of Clinical Trial to Evaluate the Symptoms in Symptomatic Contact Lens Wearers Following Application of Intranasal Tear Neurostimulator Versus Control: primary endpoint results, effect estimate with confidence interval, sample-size…
- Clinically Indicated Magnetic Resonance Imaging in Patients With Cardiac Devices: Complete Statistical AnalysisIndependent statistical analysis of Clinically Indicated Magnetic Resonance Imaging in Patients With Cardiac Devices: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01130896).
- CLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 1a): Complete Statistical AnalysisIndependent statistical analysis of CLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 1a): primary endpoint results, effect estimate with confidence interval, sample-size…
- Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- Clofarabine for Myelodysplastic Syndrome (MDS) Patients Who Failed Vidaza Treatment (tx): Complete Statistical AnalysisIndependent statistical analysis of Clofarabine for Myelodysplastic Syndrome (MDS) Patients Who Failed Vidaza Treatment (tx): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin’s Lymphoma That Has Relapsed or Not Responded to Previous Treatment: Complete Statistical AnalysisIndependent statistical analysis of Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment: primary endpoint results, effect estimate with confidence interval,…
- Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS): Complete Statistical AnalysisIndependent statistical analysis of Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS): primary endpoint results, effect estimate with confidence interval, sample-size…
- Closed-Loop Glucagon Pump for Treatment of Post-Bariatric Hypoglycemia: Complete Statistical AnalysisIndependent statistical analysis of Closed-Loop Glucagon Pump for Treatment of Post-Bariatric Hypoglycemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03255629).
- CMRIndependent statistical analysis of Eliminating Risk of Preventable Adverse Drug Events at the Hospital-community Interface of Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- CMT2014/2Independent statistical analysis of Carbetocin Myocardium Trial 2014 Part 2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03899961).
- CO2 Versus Air Insufflation for Single-balloon Enteroscopy: Complete Statistical AnalysisIndependent statistical analysis of CO2 Versus Air Insufflation for Single-balloon Enteroscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01758900).
- COASTIndependent statistical analysis of OPT-302 With Aflibercept in Neovascular Age-related Macular Degeneration (nAMD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04757636).
- Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury: Complete Statistical AnalysisIndependent statistical analysis of Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00597818).
- Cochlear Implantation for Treatment of Single-sided Deafness: Complete Statistical AnalysisIndependent statistical analysis of Cochlear Implantation for Treatment of Single-sided Deafness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02532972).
- COCOA-PADIndependent statistical analysis of Cocoa to Improve Walking Performance in Peripheral Artery Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02876887).
- COCOVIndependent statistical analysis of Care Outcomes for Chiropractic Outpatient Veterans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03254719).
- Code SepsisIndependent statistical analysis of Effects of Code Sepsis Implementation on Emergency Department (ED) Sepsis Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- CODEXIndependent statistical analysis of Evaluation of Efficacy on Exercise Tolerance of Symbicort (Budesonide/Formoterol) Compared to Placebo and Oxis in Patients With Severe COPD: primary endpoint results, effect estimate with confidence interval, sample-size…
- CoFAR7Independent statistical analysis of Baked Egg or Egg Oral Immunotherapy for Children With Egg Allergy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Cognitive Behavioral Therapy (CBT) for Anxiety Disorders in Autism: Adapting Treatment for Adolescents: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Behavioral Therapy (CBT) for Anxiety Disorders in Autism: Adapting Treatment for Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Cognitive Behavioral Treatments for Post-traumatic Stress Disorder (PTSD) Sleep Disturbance: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Behavioral Treatments for Post-traumatic Stress Disorder (PTSD) Sleep Disturbance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00108628).
- Cognitive Remediation for Cocaine Dependence: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Remediation for Cocaine Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01393457).
- Cognitive Remediation With D-Cycloserine: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Remediation With D-Cycloserine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01399866).
- COGNUTRIN in Breast Cancer Survivors: Complete Statistical AnalysisIndependent statistical analysis of COGNUTRIN in Breast Cancer Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01823991).
- ColdPlay2Independent statistical analysis of Evaluation of Effect of CryoBalloon Focal Ablation System on Human Esophageal Epithelium: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Combination Chemotherapy and Dasatinib in Treating Participants With Philadelphia Positive or BCR-ABL Positive Acute Lymphoblastic Leukemia.: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy and Dasatinib in Treating Participants With Philadelphia Positive or BCR-ABL Positive Acute Lymphoblastic Leukemia.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer: primary endpoint…
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck: primary endpoint results, effect estimate with…
- Combination Chemotherapy With or Without Rituximab in Treating Participants With Stage III-IV Classic Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy With or Without Rituximab in Treating Participants With Stage III-IV Classic Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer: primary…
- Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax: Complete Statistical AnalysisIndependent statistical analysis of Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01570036).
- Combination of GTI-2040 and Cytarabine in the Treatment of Refractory and Relapsed Acute Myeloid Leukemia (AML): Complete Statistical AnalysisIndependent statistical analysis of Combination of GTI-2040 and Cytarabine in the Treatment of Refractory and Relapsed Acute Myeloid Leukemia (AML): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Combination of Orally Inhaled BI1744CL/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease ( COPD): Complete Statistical AnalysisIndependent statistical analysis of Combination of Orally Inhaled BI1744CL/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease ( COPD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…